Global Nephrology Drugs Market Growth (Status and Outlook) 2023-2029

February 2023 | 102 pages | ID: G8AFAC4A5023EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Nephrotic drugs are used to treat nephropathy. In recent years, the increase of cases of renal failure, the increase of unhealthy lifestyle adaptation, the surge in the prevalence of chronic kidney disease, the increase of the elderly population, the increase of excessive drinking and obesity have promoted the growth of nephrotic drugs.

LPI (LP Information)' newest research report, the “Nephrology Drugs Industry Forecast” looks at past sales and reviews total world Nephrology Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Nephrology Drugs sales for 2023 through 2029. With Nephrology Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nephrology Drugs industry.

This Insight Report provides a comprehensive analysis of the global Nephrology Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nephrology Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nephrology Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nephrology Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nephrology Drugs.

The global Nephrology Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Nephrology Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Nephrology Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Nephrology Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Nephrology Drugs players cover AstraZeneca, Pfizer, Amgen, FibroGen, GlaxoSmithkline, AbbVie, Akebia Therapeutics, Teva Pharmaceutical Industries and Johnson & Johnson, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Nephrology Drugs market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• ACE Inhibitors
• Calcium Channel Blocker
• Beta Blockers
• Diuretics
• Others

Segmentation by application

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• AstraZeneca
• Pfizer
• Amgen
• FibroGen
• GlaxoSmithkline
• AbbVie
• Akebia Therapeutics
• Teva Pharmaceutical Industries
• Johnson & Johnson
• Roche

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Nephrology Drugs Market Size 2018-2029
  2.1.2 Nephrology Drugs Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Nephrology Drugs Segment by Type
  2.2.1 ACE Inhibitors
  2.2.2 Calcium Channel Blocker
  2.2.3 Beta Blockers
  2.2.4 Diuretics
  2.2.5 Others
2.3 Nephrology Drugs Market Size by Type
  2.3.1 Nephrology Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Nephrology Drugs Market Size Market Share by Type (2018-2023)
2.4 Nephrology Drugs Segment by Application
  2.4.1 Hospital Pharmacy
  2.4.2 Retail Pharmacy
  2.4.3 Online Pharmacy
2.5 Nephrology Drugs Market Size by Application
  2.5.1 Nephrology Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Nephrology Drugs Market Size Market Share by Application (2018-2023)

3 NEPHROLOGY DRUGS MARKET SIZE BY PLAYER

3.1 Nephrology Drugs Market Size Market Share by Players
  3.1.1 Global Nephrology Drugs Revenue by Players (2018-2023)
  3.1.2 Global Nephrology Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Nephrology Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 NEPHROLOGY DRUGS BY REGIONS

4.1 Nephrology Drugs Market Size by Regions (2018-2023)
4.2 Americas Nephrology Drugs Market Size Growth (2018-2023)
4.3 APAC Nephrology Drugs Market Size Growth (2018-2023)
4.4 Europe Nephrology Drugs Market Size Growth (2018-2023)
4.5 Middle East & Africa Nephrology Drugs Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Nephrology Drugs Market Size by Country (2018-2023)
5.2 Americas Nephrology Drugs Market Size by Type (2018-2023)
5.3 Americas Nephrology Drugs Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Nephrology Drugs Market Size by Region (2018-2023)
6.2 APAC Nephrology Drugs Market Size by Type (2018-2023)
6.3 APAC Nephrology Drugs Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Nephrology Drugs by Country (2018-2023)
7.2 Europe Nephrology Drugs Market Size by Type (2018-2023)
7.3 Europe Nephrology Drugs Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Nephrology Drugs by Region (2018-2023)
8.2 Middle East & Africa Nephrology Drugs Market Size by Type (2018-2023)
8.3 Middle East & Africa Nephrology Drugs Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL NEPHROLOGY DRUGS MARKET FORECAST

10.1 Global Nephrology Drugs Forecast by Regions (2024-2029)
  10.1.1 Global Nephrology Drugs Forecast by Regions (2024-2029)
  10.1.2 Americas Nephrology Drugs Forecast
  10.1.3 APAC Nephrology Drugs Forecast
  10.1.4 Europe Nephrology Drugs Forecast
  10.1.5 Middle East & Africa Nephrology Drugs Forecast
10.2 Americas Nephrology Drugs Forecast by Country (2024-2029)
  10.2.1 United States Nephrology Drugs Market Forecast
  10.2.2 Canada Nephrology Drugs Market Forecast
  10.2.3 Mexico Nephrology Drugs Market Forecast
  10.2.4 Brazil Nephrology Drugs Market Forecast
10.3 APAC Nephrology Drugs Forecast by Region (2024-2029)
  10.3.1 China Nephrology Drugs Market Forecast
  10.3.2 Japan Nephrology Drugs Market Forecast
  10.3.3 Korea Nephrology Drugs Market Forecast
  10.3.4 Southeast Asia Nephrology Drugs Market Forecast
  10.3.5 India Nephrology Drugs Market Forecast
  10.3.6 Australia Nephrology Drugs Market Forecast
10.4 Europe Nephrology Drugs Forecast by Country (2024-2029)
  10.4.1 Germany Nephrology Drugs Market Forecast
  10.4.2 France Nephrology Drugs Market Forecast
  10.4.3 UK Nephrology Drugs Market Forecast
  10.4.4 Italy Nephrology Drugs Market Forecast
  10.4.5 Russia Nephrology Drugs Market Forecast
10.5 Middle East & Africa Nephrology Drugs Forecast by Region (2024-2029)
  10.5.1 Egypt Nephrology Drugs Market Forecast
  10.5.2 South Africa Nephrology Drugs Market Forecast
  10.5.3 Israel Nephrology Drugs Market Forecast
  10.5.4 Turkey Nephrology Drugs Market Forecast
  10.5.5 GCC Countries Nephrology Drugs Market Forecast
10.6 Global Nephrology Drugs Forecast by Type (2024-2029)
10.7 Global Nephrology Drugs Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 AstraZeneca
  11.1.1 AstraZeneca Company Information
  11.1.2 AstraZeneca Nephrology Drugs Product Offered
  11.1.3 AstraZeneca Nephrology Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 AstraZeneca Main Business Overview
  11.1.5 AstraZeneca Latest Developments
11.2 Pfizer
  11.2.1 Pfizer Company Information
  11.2.2 Pfizer Nephrology Drugs Product Offered
  11.2.3 Pfizer Nephrology Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Pfizer Main Business Overview
  11.2.5 Pfizer Latest Developments
11.3 Amgen
  11.3.1 Amgen Company Information
  11.3.2 Amgen Nephrology Drugs Product Offered
  11.3.3 Amgen Nephrology Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Amgen Main Business Overview
  11.3.5 Amgen Latest Developments
11.4 FibroGen
  11.4.1 FibroGen Company Information
  11.4.2 FibroGen Nephrology Drugs Product Offered
  11.4.3 FibroGen Nephrology Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 FibroGen Main Business Overview
  11.4.5 FibroGen Latest Developments
11.5 GlaxoSmithkline
  11.5.1 GlaxoSmithkline Company Information
  11.5.2 GlaxoSmithkline Nephrology Drugs Product Offered
  11.5.3 GlaxoSmithkline Nephrology Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 GlaxoSmithkline Main Business Overview
  11.5.5 GlaxoSmithkline Latest Developments
11.6 AbbVie
  11.6.1 AbbVie Company Information
  11.6.2 AbbVie Nephrology Drugs Product Offered
  11.6.3 AbbVie Nephrology Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 AbbVie Main Business Overview
  11.6.5 AbbVie Latest Developments
11.7 Akebia Therapeutics
  11.7.1 Akebia Therapeutics Company Information
  11.7.2 Akebia Therapeutics Nephrology Drugs Product Offered
  11.7.3 Akebia Therapeutics Nephrology Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 Akebia Therapeutics Main Business Overview
  11.7.5 Akebia Therapeutics Latest Developments
11.8 Teva Pharmaceutical Industries
  11.8.1 Teva Pharmaceutical Industries Company Information
  11.8.2 Teva Pharmaceutical Industries Nephrology Drugs Product Offered
  11.8.3 Teva Pharmaceutical Industries Nephrology Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 Teva Pharmaceutical Industries Main Business Overview
  11.8.5 Teva Pharmaceutical Industries Latest Developments
11.9 Johnson & Johnson
  11.9.1 Johnson & Johnson Company Information
  11.9.2 Johnson & Johnson Nephrology Drugs Product Offered
  11.9.3 Johnson & Johnson Nephrology Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.9.4 Johnson & Johnson Main Business Overview
  11.9.5 Johnson & Johnson Latest Developments
11.10 Roche
  11.10.1 Roche Company Information
  11.10.2 Roche Nephrology Drugs Product Offered
  11.10.3 Roche Nephrology Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.10.4 Roche Main Business Overview
  11.10.5 Roche Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Nephrology Drugs Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of ACE Inhibitors
Table 3. Major Players of Calcium Channel Blocker
Table 4. Major Players of Beta Blockers
Table 5. Major Players of Diuretics
Table 6. Major Players of Others
Table 7. Nephrology Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Nephrology Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 9. Global Nephrology Drugs Market Size Market Share by Type (2018-2023)
Table 10. Nephrology Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 11. Global Nephrology Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 12. Global Nephrology Drugs Market Size Market Share by Application (2018-2023)
Table 13. Global Nephrology Drugs Revenue by Players (2018-2023) & ($ Millions)
Table 14. Global Nephrology Drugs Revenue Market Share by Player (2018-2023)
Table 15. Nephrology Drugs Key Players Head office and Products Offered
Table 16. Nephrology Drugs Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Nephrology Drugs Market Size by Regions 2018-2023 & ($ Millions)
Table 20. Global Nephrology Drugs Market Size Market Share by Regions (2018-2023)
Table 21. Global Nephrology Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 22. Global Nephrology Drugs Revenue Market Share by Country/Region (2018-2023)
Table 23. Americas Nephrology Drugs Market Size by Country (2018-2023) & ($ Millions)
Table 24. Americas Nephrology Drugs Market Size Market Share by Country (2018-2023)
Table 25. Americas Nephrology Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 26. Americas Nephrology Drugs Market Size Market Share by Type (2018-2023)
Table 27. Americas Nephrology Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 28. Americas Nephrology Drugs Market Size Market Share by Application (2018-2023)
Table 29. APAC Nephrology Drugs Market Size by Region (2018-2023) & ($ Millions)
Table 30. APAC Nephrology Drugs Market Size Market Share by Region (2018-2023)
Table 31. APAC Nephrology Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 32. APAC Nephrology Drugs Market Size Market Share by Type (2018-2023)
Table 33. APAC Nephrology Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 34. APAC Nephrology Drugs Market Size Market Share by Application (2018-2023)
Table 35. Europe Nephrology Drugs Market Size by Country (2018-2023) & ($ Millions)
Table 36. Europe Nephrology Drugs Market Size Market Share by Country (2018-2023)
Table 37. Europe Nephrology Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 38. Europe Nephrology Drugs Market Size Market Share by Type (2018-2023)
Table 39. Europe Nephrology Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 40. Europe Nephrology Drugs Market Size Market Share by Application (2018-2023)
Table 41. Middle East & Africa Nephrology Drugs Market Size by Region (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Nephrology Drugs Market Size Market Share by Region (2018-2023)
Table 43. Middle East & Africa Nephrology Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Nephrology Drugs Market Size Market Share by Type (2018-2023)
Table 45. Middle East & Africa Nephrology Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 46. Middle East & Africa Nephrology Drugs Market Size Market Share by Application (2018-2023)
Table 47. Key Market Drivers & Growth Opportunities of Nephrology Drugs
Table 48. Key Market Challenges & Risks of Nephrology Drugs
Table 49. Key Industry Trends of Nephrology Drugs
Table 50. Global Nephrology Drugs Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 51. Global Nephrology Drugs Market Size Market Share Forecast by Regions (2024-2029)
Table 52. Global Nephrology Drugs Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 53. Global Nephrology Drugs Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 54. AstraZeneca Details, Company Type, Nephrology Drugs Area Served and Its Competitors
Table 55. AstraZeneca Nephrology Drugs Product Offered
Table 56. AstraZeneca Nephrology Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 57. AstraZeneca Main Business
Table 58. AstraZeneca Latest Developments
Table 59. Pfizer Details, Company Type, Nephrology Drugs Area Served and Its Competitors
Table 60. Pfizer Nephrology Drugs Product Offered
Table 61. Pfizer Main Business
Table 62. Pfizer Nephrology Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 63. Pfizer Latest Developments
Table 64. Amgen Details, Company Type, Nephrology Drugs Area Served and Its Competitors
Table 65. Amgen Nephrology Drugs Product Offered
Table 66. Amgen Main Business
Table 67. Amgen Nephrology Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 68. Amgen Latest Developments
Table 69. FibroGen Details, Company Type, Nephrology Drugs Area Served and Its Competitors
Table 70. FibroGen Nephrology Drugs Product Offered
Table 71. FibroGen Main Business
Table 72. FibroGen Nephrology Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 73. FibroGen Latest Developments
Table 74. GlaxoSmithkline Details, Company Type, Nephrology Drugs Area Served and Its Competitors
Table 75. GlaxoSmithkline Nephrology Drugs Product Offered
Table 76. GlaxoSmithkline Main Business
Table 77. GlaxoSmithkline Nephrology Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 78. GlaxoSmithkline Latest Developments
Table 79. AbbVie Details, Company Type, Nephrology Drugs Area Served and Its Competitors
Table 80. AbbVie Nephrology Drugs Product Offered
Table 81. AbbVie Main Business
Table 82. AbbVie Nephrology Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 83. AbbVie Latest Developments
Table 84. Akebia Therapeutics Details, Company Type, Nephrology Drugs Area Served and Its Competitors
Table 85. Akebia Therapeutics Nephrology Drugs Product Offered
Table 86. Akebia Therapeutics Main Business
Table 87. Akebia Therapeutics Nephrology Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 88. Akebia Therapeutics Latest Developments
Table 89. Teva Pharmaceutical Industries Details, Company Type, Nephrology Drugs Area Served and Its Competitors
Table 90. Teva Pharmaceutical Industries Nephrology Drugs Product Offered
Table 91. Teva Pharmaceutical Industries Main Business
Table 92. Teva Pharmaceutical Industries Nephrology Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 93. Teva Pharmaceutical Industries Latest Developments
Table 94. Johnson & Johnson Details, Company Type, Nephrology Drugs Area Served and Its Competitors
Table 95. Johnson & Johnson Nephrology Drugs Product Offered
Table 96. Johnson & Johnson Main Business
Table 97. Johnson & Johnson Nephrology Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 98. Johnson & Johnson Latest Developments
Table 99. Roche Details, Company Type, Nephrology Drugs Area Served and Its Competitors
Table 100. Roche Nephrology Drugs Product Offered
Table 101. Roche Main Business
Table 102. Roche Nephrology Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 103. Roche Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Nephrology Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Nephrology Drugs Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Nephrology Drugs Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Nephrology Drugs Sales Market Share by Country/Region (2022)
Figure 8. Nephrology Drugs Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Nephrology Drugs Market Size Market Share by Type in 2022
Figure 10. Nephrology Drugs in Hospital Pharmacy
Figure 11. Global Nephrology Drugs Market: Hospital Pharmacy (2018-2023) & ($ Millions)
Figure 12. Nephrology Drugs in Retail Pharmacy
Figure 13. Global Nephrology Drugs Market: Retail Pharmacy (2018-2023) & ($ Millions)
Figure 14. Nephrology Drugs in Online Pharmacy
Figure 15. Global Nephrology Drugs Market: Online Pharmacy (2018-2023) & ($ Millions)
Figure 16. Global Nephrology Drugs Market Size Market Share by Application in 2022
Figure 17. Global Nephrology Drugs Revenue Market Share by Player in 2022
Figure 18. Global Nephrology Drugs Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Nephrology Drugs Market Size 2018-2023 ($ Millions)
Figure 20. APAC Nephrology Drugs Market Size 2018-2023 ($ Millions)
Figure 21. Europe Nephrology Drugs Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Nephrology Drugs Market Size 2018-2023 ($ Millions)
Figure 23. Americas Nephrology Drugs Value Market Share by Country in 2022
Figure 24. United States Nephrology Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Nephrology Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Nephrology Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Nephrology Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Nephrology Drugs Market Size Market Share by Region in 2022
Figure 29. APAC Nephrology Drugs Market Size Market Share by Type in 2022
Figure 30. APAC Nephrology Drugs Market Size Market Share by Application in 2022
Figure 31. China Nephrology Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Nephrology Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Nephrology Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Nephrology Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Nephrology Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Nephrology Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Nephrology Drugs Market Size Market Share by Country in 2022
Figure 38. Europe Nephrology Drugs Market Size Market Share by Type (2018-2023)
Figure 39. Europe Nephrology Drugs Market Size Market Share by Application (2018-2023)
Figure 40. Germany Nephrology Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Nephrology Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Nephrology Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Nephrology Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Nephrology Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Nephrology Drugs Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Nephrology Drugs Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Nephrology Drugs Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Nephrology Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Nephrology Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Nephrology Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Nephrology Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Nephrology Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Nephrology Drugs Market Size 2024-2029 ($ Millions)
Figure 54. APAC Nephrology Drugs Market Size 2024-2029 ($ Millions)
Figure 55. Europe Nephrology Drugs Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Nephrology Drugs Market Size 2024-2029 ($ Millions)
Figure 57. United States Nephrology Drugs Market Size 2024-2029 ($ Millions)
Figure 58. Canada Nephrology Drugs Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Nephrology Drugs Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Nephrology Drugs Market Size 2024-2029 ($ Millions)
Figure 61. China Nephrology Drugs Market Size 2024-2029 ($ Millions)
Figure 62. Japan Nephrology Drugs Market Size 2024-2029 ($ Millions)
Figure 63. Korea Nephrology Drugs Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Nephrology Drugs Market Size 2024-2029 ($ Millions)
Figure 65. India Nephrology Drugs Market Size 2024-2029 ($ Millions)
Figure 66. Australia Nephrology Drugs Market Size 2024-2029 ($ Millions)
Figure 67. Germany Nephrology Drugs Market Size 2024-2029 ($ Millions)
Figure 68. France Nephrology Drugs Market Size 2024-2029 ($ Millions)
Figure 69. UK Nephrology Drugs Market Size 2024-2029 ($ Millions)
Figure 70. Italy Nephrology Drugs Market Size 2024-2029 ($ Millions)
Figure 71. Russia Nephrology Drugs Market Size 2024-2029 ($ Millions)
Figure 72. Spain Nephrology Drugs Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Nephrology Drugs Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Nephrology Drugs Market Size 2024-2029 ($ Millions)
Figure 75. Israel Nephrology Drugs Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Nephrology Drugs Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Nephrology Drugs Market Size 2024-2029 ($ Millions)
Figure 78. Global Nephrology Drugs Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Nephrology Drugs Market Size Market Share Forecast by Application (2024-2029)